Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
Holding ALLO?
Track your performance easily

Allogene Therapeutics (ALLO) Financial Statements

1,301 Followers

Allogene Therapeutics Financial Overview

Allogene Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.608; its P/E ratio is -1.91; Allogene Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 22.00K$ -44.00K$ 43.00K
Gross Profit--$ 22.00K$ -44.00K$ 43.00K
EBIT$ -66.29M$ -66.36M$ -65.00M$ -71.93M$ -62.98M
EBITDA$ -63.09M$ -62.71M$ -61.45M$ -68.45M$ -59.40M
Net Income Common Stockholders$ -66.29M$ -66.36M$ -65.00M$ -89.26M$ -61.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 291.56M$ 444.63M$ 384.86M$ 448.70M$ 465.50M
Total Assets$ 589.12M$ 646.88M$ 586.35M$ 642.84M$ 712.33M
Total Debt$ 85.14M$ 86.99M$ 88.92M$ 88.35M$ 90.10M
Net Debt$ -206.43M$ -357.64M$ -295.94M$ -360.35M$ -375.40M
Total Liabilities$ 125.37M$ 131.84M$ 124.98M$ 130.60M$ 129.22M
Stockholders Equity$ 463.75M$ 515.03M$ 461.37M$ 512.23M$ 583.10M
Cash Flow-
Free Cash Flow$ -44.54M$ -63.59M$ -55.91M$ -53.89M$ -55.54M
Operating Cash Flow$ -44.12M$ -63.59M$ -55.90M$ -53.71M$ -55.53M
Investing Cash Flow$ -75.99M$ 74.61M$ 22.13M$ 67.46M$ -34.27M
Financing Cash Flow$ 679.00K$ 108.60M$ 1.65M$ 155.00K$ 4.29M
Currency in USD

Allogene Therapeutics Earnings and Revenue History

Allogene Therapeutics Debt to Assets

Allogene Therapeutics Cash Flow

Allogene Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis